The vaccine panel by RFK Jr.
Biostatistician and epidemiologist Martin Kulldorff, MD, PhD, and Dr. Mina Zadeh, Acip Executive Secretary, CDC, Look on As People Present Their Information to Members of the Advisory Committee on Immunization Practices, As The Us Centers for Disease Control and Prevention's (CDC) Advisory Panel for Vaccines Convenes, in Atlanta, Us June 25, 2025.
Megan Varner | Reuters
A version of this article was first published in CNBCS Healthy Return's newsletter, in which the latest health news leads directly to their inbox. Subscribe here to get future expenses.
A revised government group of vaccine advisors with newly appointed immunization skeptics voted against a mercury-containing shot ingredient that the anti-vaccination movement has long targeted.
The group, which was referred to as the advisory committee for immunization practices or ACIP, voted on Thursday with the recommendation of an annual single dose flu for the Americans and against influenza recordings that contained thimerosal no reference to damage from this preservative. It was the first acip meeting since the secretary for health and human services, Robert F. Kennedy Jr.
The centers for the control and prevention of diseases still have to unsubscribe. If the agency is the case, this would affect about 4% to 5% of the US flu vaccine supply.
The rest of the nation's flu photos was free of Thimerosal, according to the CDC data last season. But when it comes to vaccinating an entire country, said “small percentages,” said Dr. Sean O'Leary, an expert for infectious diseases at the American Academy of Pediatrics, to reporters last week.
If the few thimerosal flu shots were removed from the market,
“This would inevitably lead to fewer people to be vaccinated at least for a short time, possibly for a long time and then more hospital stays and deaths,” said O'Leary.
The recommendation also increases long -term, unfounded fears that the substance can lead to developmental disorders such as autism. Kennedy's skepticism of vaccine concluded the circle with the coordination of the body: A decade before he entered his current role, he published a book that demanded the removal of Thimerosal from Schüussen and linked it to developmental disorders.
“A very common topic of conversation against accycine is in Thimmerosal. So this is a very clear strategy to sow distrust of vaccines,” said O'Leary.
Susana Sanchez, a nurse, manages a flu vaccination to Loisy Barrera in a CVS pharmacy and in a minute clinic on September 10, 2021 in Miami, Florida.
Joe Raedle | Getty pictures
Here is why thimerosal is important. It has often been used as a preservative for decades to prevent the growth of harmful bacteria in several drugs and vaccines with several doses. More than 40 studies on many decades have not found a connection between thimerosal and developmental delays.
However, the use in approved vaccines has dropped sharply because the manufacturers have shifted to dose packaging for their recordings, which requires no preservatives. The Food and Drug Administration asked the manufacturers about 25 years ago to remove the substance from the vaccine in childhood from a lot of caution, not due to damage according to the CDC.
“The thought was that Merkur is a scary word, and just let it out, just let us do this into a non-identified one,” said O'Learly. He added that “many studies have shown that it is completely safe, have no neurological developmental disorders or other adverse effects”.
Some multi-dose forms of flu vaccine for adults still contain thimerosal, including Sanofis fluzone and two shots from the biotech company CSL SEQIRUS.
A member of the committee, Dr. Cody Meissner, Professor of Pediatrics at Dartmouth Geisel School of Medicine, said that he was concerned that the disposal of the use of multidosis vials could increase the costs for vaccination and restrict access for some groups. He also commented on concerns about the message that would send the recommendation to other countries in which the use of multi-dose of fluance vaccines is more common.
“This could restrict the availability of the Influenza vaccine for some people,” he said during the meeting after he had voted against the restriction of the flu in the Thimerosal.
Before the votes of the meeting, Lyn Redwood, a nurse who dealt with anti-access organizations was presented in Thimerosal in flu vaccine. Redwood is one of the “Mercury Mothers” who urged Kennedy to deal with Mercury and Children's Health. She also worked for years as President of the Child Health Defense, the anti-Accacine organization founded by Kennedy.
Feel free to send Annikakim.constantino@nbcuni.com tips, suggestions, ideas and data to Annika.
Latest in the healthcare system Tech: Arcadia, which was acquired by the private equity company Nordic Capital
The health data platform Arcadia was taken over by the private equity company Nordic Capital, the companies announced on Tuesday.
Arcadia puts health data into predictive knowledge that payers and providers can use to improve the care of patients, reduce costs and increase sales. The company described the deal with Nordic Capital as a “strategic partnership”, in which the company becomes Arcadia according to a publication of the “majority owners”.
Michael Meucci, CEO of Arcadia, said the cooperation with Nordic Capital would enable Arcadia to further improve his customer experience, to expand his skills for artificial intelligence, to explore new M&A opportunities and to improve growth in its core segments, including value-based care.
“It is very validating,” Meucci told CNBC in an interview. “It must be validated that there are institutional investors with large chapters that are also committed to changing us (US?) Health care and global health care as well.”
Arcadia and Nordic Capital have not disclosed the conditions of the acquisition. The deal is expected to be completed in the second half of the year, although it is still subject to regulatory permits.
Meucci said he knew the Nordic capital team for a few years and the company has observed Arcadia's progress as a company. Arcadia is profitable and carried out a successful acquisition last year. Meucci said these milestones made Nordic Capital confidently that the company was ready for the next growth phase.
Arcadia recently collected outside of the financing in 2023 when there were $ 125 million in financing Vista credit partners. The Nordic Capital acquisition serves as an exit of former investors, said Arcadia.
“This partnership corresponds seamlessly with Nordic Capital's investment strategy, and Nordic Capital is pleased to support Arcadia in his next phase of growth,” said Daniel Berglund, partner and co-manager of health care at Nordic Capital.
TripleTree served as a financial advisor for Nordic Capital for the transaction, and Lazard advised Arcadia.
“This is just a further reinforcement of our mission that we have to change the costs of health care,” said Meucci.
Read the complete publication here.
Feel free to send tips, suggestions, story ideas and data to Ashley at Ashley.capoot@nbcuni.com.
